CAR T-Cell, An Issue of Hematology/Oncology Clinics of North America, 1st Edition
特長
-
Contains 12 practice-oriented topics including CAR T-cells in aggressive B-cell lymphomas; CAR T-cells in multiple myeloma; CAR T-cells in AML; mechanisms of resistance of CAR T-cell therapy; the role of CAR T-cell therapy in the era of bispecific antibodies; and more.
-
Provides in-depth clinical reviews on CAR T-cell therapy, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
著者情報
| ISBN Number | 9780443183003 |
|---|---|
| Description Author List | Edited by Caron A Jacobson, MD, Harvard Medical School and Parth S. Shah, MD, Assistant Professor of Medicine, Pathology and Laboratory Medicine, Geisel School of Medicine at Dartmouth, Director of Genome Informatics, Dartmouth-Hitchcock, Transplant and CAR-T, Dana-Farber Cancer Institute |
| Copyright Year | 2023 |
| Edition Number | 1 |
| Format | Book |
| Trim | 152w x 229h (6.00" x 9.00") |
| Imprint | Elsevier |
| Page Count | 240 |
| Publication Date | 13 Oct 2023 |
| Stock Status | IN STOCK |
eBooks : Built for busy schedules & tailored for your goals.
Affordable knowledge, built for you
Get the resources you need-often at a lower cost than print. Quality content designed to support your goals, without stretching your budget.
Seamless access wherever you are
Always in sync
Tools the make learning stick
Your eBook is ready whenever you are!
1. Check your email for your access code.
2. Sign into or create your VitalSource account and redeem your code.
3. Open your eBook - ready whenever you are!
FAQ
The access code for your new eBook will be sent in your order confirmation email. Your code can also be accessed in your My Account section on the Elsevier webshop. If you do not receive your code within a few minutes, please check your spam folder.
Step-by-step guidance on how to download Bookshelf and also redeem your code can be found here.
The access code for your new eBook does not expire. However, we always suggest redeeming immediately after purchase to start experiencing the benefits of and insights from your purchase. Important to note - the code provided is a single use code and only valid for the edition you purchase. It does not provide access to past nor future editions of the title.
You will have unlimited access to your eBook on the device to which it was downloaded.
Discover the various learning features that our eBooks offer on the Bookshelf® Reader! For example, you can highlight different text passages, create notes and flashcards, have the text read to you, etc. Particularly practical: You can also use your eBooks offline. More information on the learning functions can be found on the Vitalsource page.
Quality is our top priority. That's why we collaborate with the leading eBook reader provider VitalSource. VitalSource has its own eBook reader Bookshelf®, which you can easily download. This reader is very user-friendly and offers more features than other standard readers. For example, you can highlight different text passages, create notes and flashcards, have the text read to you, etc. Particularly practical: You can also use your eBooks offline. More information can be found on the Vitalsource page.
Elsevier offers its eBooks in ePub format, as we believe this format is best suited to display our content ideally on as many devices as possible.
You can return your eBook within 13 days of purchase. eBooks that have been partially printed or flipped through more than 15% are excluded from returns.
Any questions ?
Chimeric Antigen Receptor T-Cell Therapy in Aggressive B-Cell Lymphoma
Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia
Chimeric Antigen Receptor T Cells in Multiple Myeloma
Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas
Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors
Early and Late Toxicities of Chimeric Antigen Receptor T-Cells
Mechanisms of Resistance to Chimeric Antigen Receptor T Cell Therapy
The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific Antibodies
The Future of Chimeric Antigen Receptor T Cell Therapy
